Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 24, 2004
- Revision received December 23, 2004
- Accepted February 3, 2005
- Published online March 1, 2005.
Copyright & Usage
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- C. PALLUD1,
- J.M. GUINEBRETIERE1,
- S. GUEPRATTE2,
- K. HACENE3,
- R. NEUMANN4,
- W. CARNEY5 and
- M.F. PICHON2
- 1Service de Pathologie, Centre René-Huguenin De Lutte Contre Le Cancer, 35 rue Dailly, 92210 Saint-Cloud, France
- 2Laboratoire d'Oncobiologie, Centre René-Huguenin De Lutte Contre Le Cancer, 35 rue Dailly, 92210 Saint-Cloud, France
- 3Service de Statistiques Médicales, Centre René-Huguenin De Lutte Contre Le Cancer, 35 rue Dailly, 92210 Saint-Cloud, France
- 4Bayer Vital GmBH, Leverkusen, Germany
- 5Oncogene Science, Bayer HealthCare Cambridge, MA, U.S A.
- Correspondence to: Dr. M.-F. Pichon, Laboratoire d'Oncobiologie, 35 rue Dailly, 92210 Saint-Cloud, France. Tel: 33 1 47 11 15 74, Fax: 33 1 47 11 15 73, e-mail: mf.pichon{at}stcloud-huguenin.org
Cited By...
Jump to section
Related Articles
Cited By...
- Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer
- Value and Limitations of Measuring HER-2 Extracellular Domain in the Serum of Breast Cancer Patients
- Serum HER-2 concentration in patients with primary breast cancer